Document Detail

Fc gamma R IIIB polymorphisms: their association with clinical manifestations and autoantibodies in SLE patients from western India.
MedLine Citation:
PMID:  20536598     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Receptors for the Fc fragment of immunoglobulin G (Fc gamma Rs) represent the link between the humoral and cellular immune responses. Polymorphisms of Fc gamma R, mainly IIA, IIB, IIIA, IIIB have been identified as genetic factors influencing susceptibility to disease or disease course of a prototype autoimmune disease like systemic lupus erythematosus (SLE). Fc gamma alleles may be associated with inefficient removal of apoptotic cells or antigens and hence may be associated with higher risk of SLE. OBJECTIVE: This study was designed to look for Fc gamma R IIIB polymorphisms of three different alleles, NA1, NA2 and SH in SLE patients and to correlate the distribution of Fc gamma R IIIB genotypes with clinical presentation and autoantibody profile. MATERIAL AND METHODS: Eighty SLE patients along with eighty normal individuals were studied. Fc gamma R IIIB polymorphism was tested by allele-specific primer amplification. RESULTS: The percentage distribution of NA1/NA1, NA1/NA2 and NA2/NA2 was 22.5%, 40% and 37.5%, respectively, among the normal population; and among SLE patients it was 25%, 40% and 35%, respectively. The percentage distribution of SH allele was 68.8% among the normal population, while in SLE patients it was 60%. No statistical difference was found in the distribution of Fc gamma R IIIB genotypes in patients of lupus nephritis and SLE without nephritis (P > 0.05). CONCLUSION: Among SLE patients studied, NA2 was the prominent allele. It was commonly associated with clinical manifestations such as skin rash, arthritis, hematological and immunological disorders. This suggests that the primary involvement of Fc gamma R IIIB NA2 allele is more likely involved with disease susceptibility of SLE.
Vandana Pradhan; Neha Deshpande; Anita Nadkarni; Manisha Patwardhan; Prathamesh Surve; Kanjaksha Ghosh
Related Documents :
23352288 - Detection of dna mutations based on analysis of multiple wavelength excitation/emission...
25206388 - A novel mutation in the sodium channel α1 subunit gene in a child with dravet syndrome...
15119548 - Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with ...
8508048 - Immunoglobulin genes in autoimmunity.
17107468 - Population structure between environmentally transmitted vibrios and bobtail squids usi...
16581088 - Mutation of albedo and growth response produces oscillations in a spatial daisyworld.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of rheumatic diseases     Volume:  13     ISSN:  1756-185X     ISO Abbreviation:  Int J Rheum Dis     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-06-11     Completed Date:  2010-09-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101474930     Medline TA:  Int J Rheum Dis     Country:  England    
Other Details:
Languages:  eng     Pagination:  138-43     Citation Subset:  IM    
Department of Autoimmune Disorders, National Institute of Immunohaematology, Indian Council of Medical Research, KEM Hospital, Parel, Mumbai, Maharashtra, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cross-Sectional Studies
Genetic Predisposition to Disease*
Health Status
Isoantigens / genetics,  immunology
Lupus Erythematosus, Systemic / genetics*,  immunology*,  physiopathology
Polymorphism, Genetic*
Receptors, IgG / genetics*
Severity of Illness Index
Reg. No./Substance:
0/Autoantibodies; 0/FCGR3B protein, human; 0/Isoantigens; 0/Receptors, IgG; 0/neutrophil-specific antigen NA1, human; 0/neutrophil-specific antigen NA2; 0/neutrophil-specific antigen SH

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes me...
Next Document:  Etoricoxib improves pain, function and quality of life: results of a real-world effectiveness trial.